Searle Licenses Beximco’s Remdesivir For Pakistan

Version Of Gilead’s Potential COVID-19 Treatment Already Launched In Bangladesh

 
• By David Wallace
  
Bangladesh_Pakistan
Searle has licensed the drug for Pakistan from Bangladesh’s Beximco • Source: Shutterstock

More from Deals

More from Business